Skip to content

CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma

  • Date Published

    August 27, 2025

Givi S, Lohnes BJ, Ebrahimi S, Riedel S, Khokhali S, Khan SA, Keller M, Wolfel C, Echchannaoui H, Bockamp E, Andre MC, Abken H, Theobald M, Hartwig UF. CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma. Int J Mol Sci. 2025 Aug 25. 26doi:10.3390/ijms26178235. PMID: 40943160